Table 1: Baseline demographics.

VariableReoperation for bleedingControl group value

Group
Age (years)51.7 ± 11.953.5 ± 9.70.16
Male (%)54.563.40.08
Race
 Caucasian %81.285.90.43
 African-American %14.910.8
BMI29.6 ± 6.329.0 ± 6.40.43
Etiology of liver disease (%)
 Hepatitis C44.636.40.11
 NASH/cryptogenic15.820.60.26
 Laennec’s9.012.70.28
 Cholestatic (PBC, PSC)9.911.90.55
 Othera8.99.00.98
MELD Score23.8 ± 8.120.4 ± 7.9<0.001
ICU prior to liver transplant (%)23.212.90.005
Comorbidities
 Dyslipidemia12.913.60.85
 Diabetes21.826.30.33
 CAD5.03.50.47
 CRI10.97.50.24
 Hypertension51.547.30.42
Baseline lab values
 Platelet count (×109/L)88.879.90.14
 Hematocrit26.0 ± 8.025.8 ± 8.90.80
 INR2.1 ± 0.91.9 ± 0.90.04
Split liver transplant (%)1.00.250.30

Data presented as percent or mean ± standard deviation.
aOther diagnoses include autoimmune hepatitis, alpha 1 antitrypsin deficiency, hemochromatosis, fulminant liver failure, Budd-Chiari syndrome, Wilson’s disease, polycystic liver disease, nonhepatocellular carcinoma neoplastic disease, sarcoidosis, secondary biliary cirrhosis, Caroli’s disease, and cystinosis.
NASH: nonalcoholic steatohepatitis; PBC: primary biliary cirrhosis; PSC: primary sclerosing cholangitis; MELD: Model for End-Stage Liver Disease; BMI: body mass index; CAD: coronary artery disease; CRI: chronic renal insufficiency; INR: international normalized ratio.